1-3 of 3
Joseph M Gozgit, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Comparative TKI Profiling Analyses to Explore Potential Mechanisms of Ponatinib-Associated Arterial Thrombotic Events

Victor M. Rivera, PhD, Justin R. Pritchard, PhD, Francois Gonzalvez, PhD, Theresa Baker, Joseph M. Gozgit, PhD, Graeme Hodgson, PhD
Journal: Blood
Blood (2014) 124 (21): 1783.
https://doi.org/10.1182/blood.V124.21.1783.1783
Published: 2014
Journal Articles

Comprehensive Analysis Of The In Vitro Potency Of Ponatinib, and All Other Approved BCR-ABL Tyrosine Kinase Inhibitors (TKIs), Against a Panel Of Single and Compound BCR-ABL Mutants

Joseph M Gozgit, PhD, Alexa Schrock, PhD, Tzu-Hsiu Chen, Tim Clackson, PhD, Victor M. Rivera, PhD
Journal: Blood
Blood (2013) 122 (21): 3992.
https://doi.org/10.1182/blood.V122.21.3992.3992
Published: 2013
Journal Articles

Effects of a Novel, Selective Jak2 Inhibitor, AZ60, on STAT5 Signaling and Cellular Growth in Jak2 V617F Cell Lines.

Joseph M. Gozgit, PhD, Geraldine A. Bebernitz, BS, Pankaj Patil, MS, Minwei Ye, MS, Jiaquan Wu, PhD, Stephanos Ioannidis, PhD, Audrey Davies, BS, Tao Wang, PhD, Dennis Huszar, PhD, Michael Zinda, PhD
Journal: Blood
Blood (2007) 110 (11): 3549.
https://doi.org/10.1182/blood.V110.11.3549.3549
Published: 2007